C ell fate specification of many cell types requires the repression of specific genes and the maintenance of this gene silencing over time. Polycomb repressive complexes 1 and 2 (PRC1 and PRC2) are key developmental regulators that act on the chromatin of target genes to stably repress them. PRC1 and PRC2 each have four core subunits, whose activities have been individually characterized (1) . PRC2 methylates histone H3 at lysine 27 (H3K27me3), which is required for the silencing of Hox genes. Hox genes are master regulators of body patterning, and hence misexpression leads to defects in patterning (2) (3) (4) . How H3K27me3 leads to silencing remains unclear. Canonical PRC1 has a chromodomain-containing subunit that binds to H3K27me3 (1) . Thus, it is thought that PRC1 is the effector of silencing. Individual subunits of PRC1, including Ring1B and Phc2, have been studied to determine which of their activities are required for silencing and proper body patterning. Whereas the histone H2A ubiquitylating function of Ring1B appears dispensable (5, 6) , the self-polymerizing activity of Phc2 is required for patterning (7) . Here, we examined the requirement for a third activity: the ability of canonical PRC1 to compact adjacent nucleosomes into globular structures (8) (9) (10) .
The compaction function of PRC1 has been mapped to an intrinsically disordered region with high positive charge within the complex (10) . In Drosophila, the Posterior sex comb (Psc) subunit carries this compaction region which, when truncated, leads to Hox gene misexpression (9, 11) . The extent of deletion of this region in Psc mutant alleles correlates with the severity of the mutant phenotypes, suggesting that compaction is critical for PRC1 function during Drosophila development. In mammals, compaction is driven by the CBX2 subunit (10); CBX2 is one of five homologs of Polycomb (Pc), each of which forms different versions of PRC1 (1) . To test the role of the CBX2 compaction region in gene silencing and body pattern formation, we introduced point mutations that disrupt the in vitro ability of CBX2 to compact nucleosomes, as characterized in (10), into mouse embryonic stem cells (mESCs) and mice, and assessed the resultant phenotypes.
We first verified that CBX2 is a component of PRC1 in wild-type mESCs ( fig. S1 ). To examine the role of compaction, we expressed, using doxycycline induction in Cbx2 −/− mESCs, wild-type CBX2 (CBX2   WT   ) or one of two previously characterized CBX2 variants, CBX2  23KRA and CBX2   DEA   .  CBX2 23KRA has 23 lysine (K) and arginine (R) residues mutated to alanine (A) in its compaction region, which should render it compaction inactive, whereas CBX2
DEA is a compaction proficient control where aspartic acid (D) and glutamic acid (E) residues are mutated to alanine in the same region (Fig. 1A and fig. S2A ) (10 S2C ), indicating appropriate complex formation. This is consistent with previous findings that mutations in the compaction region do not affect CBX2-Ring1B interaction (10, 12) . In addition, CBX7, which is the dominant Pc homolog in mESCs, also coimmunoprecipitated with Ring1B in the presence of CBX2
23KRA
, suggesting that CBX2
23KRA does not interfere with the formation of an alternate form of canonical PRC1 ( fig. S2C ).
To determine whether mutations that disrupt the in vitro compaction activity of CBX2 affect gene expression, we measured RNA levels genomewide in mESC lines before and after induction of wild-type and variant CBX2. We used the mESC lines described above that express equivalent levels of the various CBX2 proteins and a condition in which CBX2
23KRA expression was induced to a higher level (Fig. 1B) to determine whether more CBX2 23KRA would lead to CBX2 WT -like activity. Many CBX2-bound genes and known PRC1 targets were repressed after introduction of CBX2 WT (Fig. 1C, columns 1 and 2, and fig. S3A ). Notably, this repression was weaker in the presence of CBX2 23KRA (Fig. 1C , columns 4 and 5), even when 
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CBX2
23KRA was expressed at a higher level than CBX2 WT (Fig. 1C, column 6, and fig. S3A ). In contrast, expression of CBX2 DEA resulted in repression similar to that observed with CBX2 WT (Fig.  1C, column 3, and fig. S3A ). Hierarchical clustering analysis of the gene expression changes revealed that the CBX2 WT and CBX2 DEA mESC lines clustered together, whereas the CBX2 23KRA lines formed a separate cluster (Fig. 1C) . At the singlegene level, CBX2-bound genes displayed decreased mRNA levels after CBX2
WT and CBX2 DEA expression (Fig. 1D , blue tracks) but remained unchanged after CBX2
23KRA expression (red tracks). In contrast, non-PRC1 targets were unaffected by the expression of any of the CBX2 variants ( fig. S3B ). Gene expression changes were verified by reverse transcription quantitative polymerase chain reaction (RT-qPCR) analyses (Fig. 2A) . We conclude that CBX2
23KRA has less repressive activity than CBX2 WT , suggesting a correlation between repression and compaction activity.
We sought to determine whether the mutations in CBX2
23KRA might have affected the targeting of PRC1 to chromatin, thereby indirectly affecting gene repression. We determined CBX2
23KRA binding sites using a standard chromatin immunoprecipitation sequencing (ChIP-seq) protocol, . (A) Gene expression changes by RT-qPCR analyses in mESC lines. Mean ± SD; n = 4 biological replicates. **P < 0.01, *P < 0.05, t test. (B and C) ChIP-qPCR analyses for CBX2 (B) and Ring1B (C) binding. Mean ± SD; n ≥ 3 biological replicates. For (C), there are no statistically significant differences between -dox and +dox pairs, or between WT+dox and 23KRA+dox samples.
which involves cross-linking between DNA and lysine residues in the target protein. As CBX2 23KRA and CBX2
WT differ substantially in the number of lysine residues, the respective ChIP signal intensities are not comparable ( fig. S4, A and B) , but the locations for binding can be compared. We found that the binding sites of CBX2
23KRA and CBX2
WT highly overlap (85%) ( fig. S4C ). We verified by ChIP-qPCR that CBX2
23KRA is present at genes that it failed to repress (Fig. 2B) . We also assessed the occupancy of other PRC1 components and found that Ring1B, a core component of all PRC1 complexes, and CBX7 are both bound at equivalent levels in CBX2 23KRA and CBX2
WT mESCs ( Fig. 2C and fig. S5A ). Therefore, CBX7, which does not compact nucleosomes in vitro, is insufficient for full repression by PRC1 without wildtype CBX2. The PRC1-and PRC2-deposited histone modifications H2AK119Ub and H3K27me3 were also present at similar levels in CBX2 23KRA and CBX2
WT mESCs ( fig. S5 , B and C). These data suggest that mutations that are expected to inhibit CBX2-mediated nucleosome compaction result in disrupted gene repression without affecting the assembly of PRC1 on chromatin.
Because mutations in the compaction region of CBX2 disrupted gene repression in mESCs, we hypothesized that they would also affect PRC1 function during embryogenesis. We therefore generated mouse lines that carried either the Cbx2 23KRA or Cbx2 13KRA mutations (figs. S6 to S8). The CBX2 13KRA mutant contains a subset of the mutations in CBX2 23KRA (Fig. 1A and fig. S6A ) and has in vitro compaction activity lower than that of CBX2 WT animals were viable, and the respective mutant alleles were expressed normally in vivo ( fig. S6C ).
Thus, we generated two distinct mouse lines containing alleles of compaction-deficient Cbx2 with distinct compaction abilities. If the compaction activity of CBX2 is important for PRC1 function, we would expect the Cbx2 23KRA and Cbx2 13KRA homozygotes to exhibit anterior-to-posterior transformations spanning the axial skeleton, the classic PcG phenotype found in Cbx2 −/− mice (13, 14) . In fact, Cbx2
23KRA/23KRA
and Cbx2 13KRA/13KRA animals exhibited posteriorization across the vertebral column, similar to that observed in Cbx2
, with C7-to-T1, T1-to-T2, T7-to-T8, T13-to-L1, and L6-to-S1 transformations (Fig. 3 and fig. S9 ). This indicated that both Cbx2 23KRA/23KRA and Cbx2 13KRA/13KRA mimic Cbx2 −/− in axial patterning. The transformations and their penetrance resemble the null phenotypes of two other PRC1 subunits, Phc2 and Bmi1 (Table 1) Given that CBX2 23KRA is less active in vitro than CBX2
13KRA , we compared the severity of the phenotypes between the two mutants. C7-to-T1 transformations were more dramatic in Cbx2 23KRA/23KRA than in Cbx2 13KRA/13KRA : Cbx2 23KRA/23KRA exhibited long ectopic C7 cervical ribs that articulated to the sternum or T1 rib (Fig. 3, C and G) , whereas Cbx2 13KRA/13KRA displayed increased incidence of C7 rib anlage when compared with Cbx2 +/+ (Fig. 3, A, B , E, and F, and Table 1 ). The frequencies of the other transformations were consistently higher in Cbx2 23KRA/23KRA compared with Cbx2
13KRA/13KRA (Table 1) . For L6-to-S1 (Fig. 3 , K to Q) and T7-to-T8 ( fig. S9 , A to E), the occurrences of bilateral changes were higher in Cbx2 23KRA/23KRA (Table  1) , and T13-to-L1 (Fig. 3M and fig. S9 , F to H) was only observed in Cbx2 23KRA/23KRA (Table 1) . Thus, the skeletal abnormalities collectively indicated that the Cbx2 23KRA mutation resulted in more severe phenotypes than Cbx2
13KRA
. Although we note that the two mutant alleles are in different genetic backgrounds, it is striking that the relative severity of the mutant phenotypes correlates with the in vitro activity of CBX2 23KRA and CBX2
.
Cbx2
−/− mice display other phenotypes in addition to the classic PcG homeotic transformations; these include postnatal lethality, reduced body weight, and male-to-female sex reversal (13, 14) . Notably, we did not observe any of these phenotypes in Cbx2 23KRA/23KRA and Cbx2
animals ( fig. S10) . S11B ), suggesting that binding of all PRC1 complexes on chromatin is unperturbed by the CBX2 mutations. Together these observations indicate that the effects of the mutations in the compaction region of CBX2 are exerted in a specific manner, consistent with the hypothesis that nucleosome compaction is necessary for proper patterning of the body axis during development.
Here, we show that the compaction region of CBX2 plays a key role in establishing proper axial patterning, thereby expanding the functional regions of this protein. The N-terminal chromodomain of CBX2 binds to H3K27me3, the histone modification that marks developmental genes for silencing. Thus, CBX2 has the dual function of targeting PRC1 to H3K27me3-marked genes and effecting PRC1-dependent gene repression via its compaction region. The other Pc homologs CBX4, CBX6, CBX7, and CBX8 have weak or no compaction activity (10) , and their null mutants do not exhibit posterior transformation phenotypes, unlike Cbx2 −/− or Cbx2 23KRA and Cbx2 13KRA mutants (16) . We infer from this that the regulation of Hox genes for patterning during development is particularly dependent on compaction that is mediated by CBX2; testing this proposed mechanism requires an assay for local compaction in the relevant cell types in mice, which is not currently available. PRC1 also mediates subnuclear clustering through its Polyhomeotic subunit, whose self-polymerizing function is also needed for axial patterning (7, 17) . We therefore propose a model in which PRC1 organizes nucleosomes by coordinating local chromatin compaction and subnuclear clustering, thus creating structures that are refractory to transcription and thereby instilling stable silencing.
